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The purpose of this review is to examine human research studies published within
the past 6 years which evaluate the role of anthocyanin, flavanol, and flavanone
consumption in cognitive function, and to discuss potential mechanisms of action
underlying any observed benefits. Evidence to date suggests the consumption of
flavonoid-rich foods, such as berries and cocoa, may have the potential to limit, or even
reverse, age-related declines in cognition. Over the last 6 years, the flavonoid subgroups
of anthocyanins, flavanols, and flavanones have been shown to be beneficial in terms
of conferring neuroprotection. The mechanisms by which flavonoids positively modulate
cognitive function are yet to be fully elucidated. Postulated mechanisms include both
direct actions such as receptor activation, neurotrophin release and intracellular signaling
pathway modulation, and indirect actions such as enhancement of cerebral blood flow.
Further intervention studies conducted in diverse populations with sufficient sample
sizes and long durations are required to examine the effect of consumption of flavonoid
groups on clinically relevant cognitive outcomes. As populations continue to focus
on adopting healthy aging strategies, dietary interventions with flavonoids remains a
promising avenue for future research. However, many questions are still to be answered,
including identifying appropriate dosage, timeframes for intake, as well as the best form
of flavonoids, before definitive conclusions can be drawn about the extent to which their
consumption can protect the aging brain.
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INTRODUCTION
Flavonoids are a class of polyphenols found in plant-based foods and are categorized into six major
subclasses: anthocyanins, flavanols, flavonols, flavanones, flavones, and isoflavones (Spencer, 2008).
Fruits and vegetables, wine, tea, and cocoa contain high concentrations of flavonoids (Somerset and
Johannot, 2008). Structurally, flavonoids consist of two aromatic carbon rings (benzopyran A and
C rings), and a benzene (B) ring, and may be divided into various subgroups based on the degree of
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the oxidation of the C ring, the hydroxylation pattern of the
ring structure, and the substitution of the three-position. Once
ingested, flavonoids undergo extensive metabolism in the small
and large intestine, in the liver, and within cells, resulting
in forms in the body distinct from those consumed in foods
(Manach et al., 2005).
The reduction in risk of cardiovascular disease and some
cancers afforded by intake of flavonoids is well known (Kampa
et al., 2007; Chong et al., 2010), and more recently, there has been
attention directed toward their potential to improve cognitive
performance in older adults, and thereby potentially protect
against neurodegenerative diseases such as Alzheimer’s disease
(AD) (Bergland et al., 2019; Chai et al., 2019). In light of the
projections indicating rapid increases in the prevalence of AD,
and in the absence of successful treatments, alternative measures
to slow the development and progression of the disease are
imperative: flavonoid intake is being investigated as one such
alternative measure.
Studies using animal models [reviewed in Nehlig (2013),
de Andrade Teles et al. (2018), Hajialyani et al. (2019)] have
demonstrated that flavonoids may slow or even reverse the effects
of aging and dementia of which AD is the most common form.
For example, in a rat model of aging which demonstrates
inflammation, oxidative stress, memory and synaptic
dysfunction, intraperitoneal injection of 100 mg/kg anthocyanins
daily for 7 weeks, significantly improved spatial learning and
memory ability, as well as short term memory (Rehman et al.,
2017). Moreover, spatial learning and memory impairments were
prevented in 4-month-old male senescence-accelerated mouse
prone-8 (SAMP8) animals, orally administered 0.05 or 0.1%
green tea catechins in drinking water for 6 months (Li et al.,
2009). SAMP8 is typically characterized by early onset of learning
and memory deficits along with spontaneous overproduction of
soluble Aβ in the brain, a hallmark of AD.
While existing animal studies provide important insights into
the neuroprotective properties of flavonoids and their underlying
mechanisms, these studies cannot provide information regarding
potential effects on more complex human cognitive functions
such as abilities underpinned by language, and those supported
by multifaceted organization of information, i.e., executive
function. Consequently, clinical studies are required to determine
if the beneficial effects observed in animal models are replicable
in human populations.
The purpose of this narrative review is to examine
human research studies published within the past 6 years
(2014–2020 inclusive), to evaluate associations between intake
of products containing the flavonoid subclasses of anthocyanins,
flavanols, and flavanones and cognitive function (summarized
in Supplementary Table 1 and Table 1). Potential mechanisms
underlying any observed benefits will also be discussed. Studies
preceding this timeframe have been comprehensively reviewed
elsewhere; e.g., Spencer, 2010; Lamport et al., 2012; Crichton
et al., 2013. We focused on the three subclasses of anthocyanins,
flavanols, and flavanones as the effects of the additional three
flavonoid subclasses (flavones, flavonols, and isoflavones) have
not been reported in human studies published within the 6-year
timeframe of this narrative review.
METHODS
A computer-based search of PubMed was conducted for
relevant articles published between 2014 and 2020 inclusive,
with cognitive function as the primary or secondary outcome.
Search terms were: (flavonoids or anthocyanins or flavanols or
flavanones) and (cognition or cognitive function). The search was
limited to articles in humans, published in English. Studies that
specifically focused on the cognitive effects of flavonoids either in
extract or whole food form were included.
Titles and abstracts were screened by the first author to ensure
they examined the relationship between one of the flavonoid
subclasses of interest (anthocyanins, flavanols, or flavanones)
and cognition in adults. Articles were included if they reported
prospective, retrospective or intervention studies and were either
cross-sectional or longitudinal in nature. There were no strict
criteria relating to the inclusion of controls or the quality of
these controls with respect to matching for other macro or
micronutrients. Studies were excluded if they; (1) were not peer-
reviewed, (2) were a conference proceeding abstract, (3) were a
review or theoretical article, (4) were published in a language
other than English, (5) were conducted in animal models, or (6)
were conducted in children (age <18 years). The reference lists of
included articles were screened and additional articles which met
inclusion criteria were added via hand search. Included studies
are presented in Supplementary Table 1 and Table 1.
ANTHOCYANINS
Anthocyanins are a class of flavonoids concentrated in purple
and red fruits. In summary, we have reviewed four acute
studies (<24 h) and eight chronic studies (duration between
12 and 24 weeks) investigating cherry, blackcurrant, bilberry,
and blueberry anthocyanins in participants with varying
cognitive status, ranging from cognitively normal (both
young and older adults), self-perceived cognitive decline, and
objectively determined mild cognitive impairment (MCI), to
diagnosed dementia.
A 12-week randomized clinical trial conducted in 49 adults (24
intervention group, 25 control group) over the age of 70 years
with mild to moderate AD, found consumption of 200 ml/day
of cherry juice resulted in improvements in verbal fluency, short
term memory, and long term memory compared to the control
group, which consumed a juice with negligible anthocyanin
content. The intervention group also had a reduction in systolic
blood pressure, with a trend for reduction in diastolic blood
pressure. However, markers of inflammation (CRP, C-reactive
protein; IL-6, Interleukin 6) were not altered (Kent et al., 2017);
suggesting either the mechanism of action of anthocyanins
is not through the inflammatory pathway, or perhaps more
likely, that the advanced disease stage which is accompanied by
significant pathological hallmarks and inflammation, masked any
potential anti-inflammatory effects conferred by the cherry juice.
Of note, pre-clinical studies have indicated that anthocyanins
from berry fruits may require only a few weeks to accumulate
in brain regions associated with cognition (Willis et al., 2009).
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Chocolate consumption was significantly
and positively associated with the global
composite, visual-spatial memory and
organization, scanning and tracking,
verbal episodic memory, working
memory, Wechsler Adult Intelligence
Scale Similarities Test, and MMSE
MCI, Mild Cognitive Impairment; MMSE, Mini-Mental State Examination.
Twelve-week consumption of two cups of Montmorency tart
cherry juice per day resulted in better performance on the
paired associates learning task which assesses visual memory
(mean difference of −8.5; 95% −12.5 to −4.5; p = 0.02), and
significantly better movement time scores on the Reaction Time
test which measures speed of response (mean difference of−10.4;
95% −13.4 to −7.5; p = 0.03), compared to the control group.
This study was conducted in 37 adults aged between 65 and
80 with normal cognitive function. There were no significant
improvements in working memory and strategy use, and visual
attention. It is, however, important to note, that the intervention
group had significantly decreased physical activity level whilst the
control group had significantly increased cholesterol intake over
the intervention period (Chai et al., 2019): factors which may have
impacted the outcome measures.
In contrast, Caldwell et al. (2016) found no change in
acute memory following consumption of a 300 ml serving
of cherry juice, either administered as a single serving at
time “0,” or three 100 ml servings at “0,” 1, and 2 h,
with cognitive testing occurring at time “0” and 6 h post-
intervention, in six young healthy participants, five older
adults, and five older adults with dementia. The cognitive
tests assessed verbal learning and memory, higher executive
function, and speed of processing. The serving of cherry juice
contained approximately 55 mg of anthocyanins; a lower dose
compared to other food-based studies. The cognitive tests
administered may not have adequately assessed the cognitive
domains affected by acute anthocyanin consumption. Moreover,
testing at 2 rather than 6 h post-intervention may better
reflect the physiological absorption of anthocyanins in the
small intestine.
In an intervention trial undertaken in 36 healthy young
participants (aged 18–35 years), individuals consumed one of
three different treatment drinks once, with at least 7 days
of washout between consumption of each drink. The drinks
contained either 0 mg of polyphenols (control), 525 ± 5 mg
of polyphenols per 60 kg of bodyweight from an anthocyanin-
enriched blackcurrant extract, or from 142 ml of a cold-
pressed blackcurrant fruit juice. Participants underwent 10 min
of cognitive testing before consumption of each treatment
drink, followed by additional cognitive testing 60 min post-
consumption, comprising seven repetitions of the 10-min
battery. Improvements in accuracy on the Rapid Visual
Information Processing task were found after supplementation
with the extract drink (p = 0.011), and improvements in
reaction time on the digit vigilance task after supplementation
with the juice treatment, at repetitions 1 (p = 0.028), 4
(p = 0.011), and 7 (p = 0.038). The juice drink also induced
a number of neuroendocrinological and physiological effects
including increase in blood glucose concentration compared
with control. These results suggest that the degree of processing
and the cultivar of blackcurrant fruit used substantially alters
the neuroendocrinological and cognitive benefits conferred
(Watson et al., 2015).
A pilot study measuring cognition as a secondary endpoint
following 16-week consumption of two Medox R© capsules
per day (total daily intake of 320 mg anthocyanin from
bilberry and blackcurrants) found improved verbal memory
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scores in the subdomains of learning (p = 0.016), recall
(p < 0.001), and recognition (p = 0.047). Improved cognitive
speed (p < 0.001) and inhibition (p = 0.044) were also
observed, whilst no improvements in executive functioning
were seen. The intervention group was comprised of eight
participants with MCI, and 19 with stable non-obstructive
coronary artery disease, as the study was designed to
investigate supplementation in those with increased risk
of dementia. However, the control group did not undergo
cognitive testing; consequently, these results should be
interpreted with caution due to the lack of a comparison
group (Bergland et al., 2019).
Several randomized, double-blinded, placebo-controlled
studies to evaluate the effects of blueberry consumption on
cognition have been conducted. In 112 adults aged 65–80, Whyte
et al. (2018) investigated the effect of 6-month consumption
of; (1) whole wild blueberry powder containing 1.35 mg
total anthocyanin per dose (WBP500), (2) whole wild
blueberry powder containing 2.7 mg total anthocyanin per
dose (WBP1000), or (3) purified extract containing 7 mg
total anthocyanin per dose (WBE111), compared to placebo.
Cognitive testing occurred at baseline, 3 and 6 months using
a battery targeting episodic memory, working memory, and
executive function. At the 3-month testing point, delayed word
recognition and short-term spatial episodic memory were
significantly better in the WBE111 treatment group compared
to control. There were no significant differences at 6 months,
or with consumption of the WBP500 and WBP1000 at any
timepoint. It should be noted, however, that the quantity of
anthocyanins administered is relatively small compared to
other studies. Miller et al. (2018) recruited 13 men and 24
women between the ages of 60 and 75 to consume either 24 g
of freeze-dried blueberries (containing 19.2 mg/g anthocyanins),
or placebo for 90 days, with cognitive testing conducted at
baseline, 45, and 90 days. Participants in the blueberry group
showed a greater reduction in switch stimuli errors (measure
of executive function) across visits compared to the control
group [F(2,70) = 3.587; p = 0.033; ηp2 = 0.09]. Participants in
the blueberry group also made fewer repetition errors on the
California Verbal Learning Test free recall (measure of verbal
memory) at 90 days compared to baseline, whilst the control
group demonstrated increased errors compared to baseline
[F(1,35) = 5.024; p = 0.031; ηp2 = 0.126]. No effect of the
intervention was seen on tests of psychomotor speed, short-term
memory, spatial cognition, or attention.
A single-blind, randomized, placebo-controlled, between-
subjects study investigated executive function changes over
a 6-h period following consumption of a 400 mL smoothie
containing equal blueberry, strawberry, raspberry, and blackberry
(n = 20), or placebo (n = 20) in 20–30 years old. Following
berry intervention, participants maintained accuracy in executive
function, up to and including the 6-h testing point, measured
using the Modified Attention Network Task (MANT) and
Task Switching Task (TST). Participants demonstrated quicker
response times in the MANT conducted at the 2- and 4-h post-
smoothie consumption cognitive assessments, and in the TST
at 6-h post-smoothie consumption. The results of this study
suggest that berry-related benefits were more evident during
periods of fatigue, with placebo participants showing decreased
performance across the 6 h as they became cognitively fatigued.
Whilst the placebo was matched to the intervention for sugar
content and sweetness, it was not matched for berry flavor, thus
participants may have guessed which treatment they received,
potentially leading to performance being influenced by placebo
effect (Whyte et al., 2019).
A cross-over randomized controlled trial was conducted in
18 older adults (aged 60–75) using a flavonoid-rich blueberry
beverage drink (579 mg of antho- and pro-cyanidins), or sugar-
matched control. Cognitive function was assessed at baseline,
2- and 5-h post-beverage consumption. Whilst there was no
significant effect of consumption of the flavonoid-rich beverage
on global cognition compared to the control drink, there was
a decline in performance in the control group from the 2-h
to the 5-h assessment [F(1,36) = 4.60; p = 0.04], which was
not observed in the intervention group. There were also no
significant differences between groups in performance on the 14
tasks that comprised the global cognitive function score; although
some associations were approaching significance, suggesting that
the study may be underpowered (Dodd et al., 2018).
Sixty-five men and women aged 62–80 years completed
a 24-week randomized double-blind, placebo-controlled trial
consuming either daily fish oil, daily blueberry (providing
269 mg anthocyanin per day), both fish oil and blueberry,
or control. Participants all reported mild, age-related cognitive
decline, but lacked a diagnosis of MCI or dementia. No effect
on motor speed, working memory, learning and retention, or
lexical access was observed for the fish oil group, compared
to placebo, at the end of the 24-week intervention, or at
48-week follow-up. There was improved discrimination in
recognition memory for the blueberry treated group at 24-weeks,
indicating improved resistance to interference of extraneous
material in memory; however, this benefit was not maintained
at week 48. Unexpectedly, there was no effect on any cognitive
domain of the combined fish oil and blueberry treatment
(McNamara et al., 2018).
In a randomized, double-blind placebo-controlled trial of
16 older adults (aged 68–92 years) with MCI, functional
magnetic resonance imaging (MRI), conducted during a working
memory task, was assessed pre- and post- 16-weeks of
blueberry supplementation (providing 269 mg anthocyanins
daily). Whilst there was no clear indication of working memory
enhancement associated with supplementation, enhanced neural
response during the working memory task was observed in
the blueberry treatment group compared to placebo. Accuracy
for the treatment group in the 1-back task was trending
toward significance (p = 0.08; participants had to recognize
when the currently displayed letter was the same as the letter
displayed one item previously), with the authors stating that the
large observed effect size (d = 1.02) indicated that increasing
the sample size from 8 to 17 per group would have been
sufficient to achieve significance at p = 0.05 with power = 0.80
(Boespflug et al., 2018).
Change in performance on cognitive tests was not significantly
different between placebo and blueberry supplementation
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treatment groups in a 12-week double-blind randomized
controlled trial of 26 cognitively normal participants aged
over 65 years. Participants underwent computerized tests of
psychomotor function, visual processing, executive function,
verbal and spatial memory, and working memory. The
percentage change in performance on the 2-back test did,
however, show weak evidence for improvement in the blueberry
treatment group compared to placebo (Bowtell et al., 2017).
Of the 12 studies reviewed in this section, six reported
improvements in at least one cognitive domain following
anthocyanin consumption (four chronic studies and two acute),
whilst six studies showed no improvement or change compared
with placebo (four chronic studies and two acute). Cognitive
domains impacted by anthocyanin intake included verbal
fluency, short term memory, long term memory, visual memory,
speed of response, accuracy, verbal memory, and executive
function. Several cognitive domains including verbal memory
and executive function were observed as being both impacted by
anthocyanin intake in some studies but not affected in others;
the possible reasons for these disparate results including cohort
differences and dose are discussed in the “Discussion.”
FLAVANOLS
Chocolate and cocoa products are a rich source of flavonoids
with flavanols, and in particular epicatechin, being the most
common type present in cocoa. High levels of flavanols are
also found in tea, red wine, and fruits such as grapes and
apples. In summary, we have reviewed two observational studies,
six acute studies (<24 h) and seven chronic studies (duration
between 1 and 6 months) investigating flavanols from fruit and
vegetables, grape juice, cocoa, and apples in mainly cognitively
normal participants (both young and older adults), with one
MCI cohort.
A recently published intervention study of 211 healthy older
adults (50–75 years) found a significant intake level-dependent
treatment effect, compared to placebo, on hippocampal-
dependent list-learning performance, following 12-weeks of
flavanol intake (260, 510, or 770 mg/day cocoa flavanols).
However, object recognition and prefrontal cortex-dependent list
sorting performance did not improve. Eight weeks post-cessation
of flavanol consumption, there were no observable effects
remaining on list-learning performance in the intervention group
compared to placebo. Notably, the object recognition task was
newly developed, and data analysis suggested the task was so
difficult that the majority of participants performed no better
than chance; thus, failure to observe associations with flavanol
intake may have been due to the psychometric properties of this
outcome measure (Sloan et al., 2021).
Gratton et al. (2020) showed that flavanol intake can improve
efficiency in blood oxygenation during hypercapnia (carbon
dioxide-dependent increase in cerebral blood flow), and that this
is likely to contribute to improvements in cognitive function,
only when cognitive demand is high; significant associations
were only observed in the Double Stroop Task and not in
the standard Stroop Task. This study was conducted in 18
healthy males (18–45 years) using an acute, randomized, placebo-
controlled, double-blind, crossover design, with high or low
cocoa flavanol drink, and cognitive function assessed pre- and
2-h post-consumption (using a Modified Stroop Task). One
advantage of this study is the intervention and placebo were
matched for macronutrient and micronutrient content, including
caffeine. With the cohort comprising only young males, future
work should be extended to include females as well as older
at-risk populations.
A study retrospectively analyzing data from 55 participants
with amnestic MCI (29 males and 26 females, aged 56–
75) found dietary supplementation with cocoa flavonoids was
associated with slowed cognitive decline. Specifically, participants
were divided into two groups depending on change in Mini-
Mental State Examination (MMSE) score at 1-year follow-up
(Group 1 = stable or improved, Group 2 = decreased by at
least three points). Intake of the commonly used nutraceutical
Mexenion R© was examined. Mexenion R© is composed of cocoa
polyphenols (240 mg/sachet), Bacopa monnieri (110 mg/sachet),
group B vitamins, vitamin E, and folic acid. Group 1 had
a significantly higher rate of Mexenion R© intake compared to
Group 2 which demonstrated decline in cognitive function at
1-year follow-up [χ2 = 13.79, p < 0.001; 29]. However, given
the formulation of Mexenion R©, it is not possible to determine
directly if the cocoa polyphenols present were responsible for the
observed benefit.
Neshatdoust et al. (2016) conducted a randomized, controlled,
double-masked, crossover dietary intervention involving 40
cognitively normal participants, aged 68.3 ± 3.0, who consumed
either a high flavanol cocoa drink (494 mg flavanols) or a low
flavanol cocoa drink (23 mg flavanols) for 28 days. After the
first intervention period, there was a 4 week wash out prior
to switching treatment. A cognitive battery measuring global
executive function, and blood sample collection was completed
pre-intervention, post-first intervention, and at the end of the
study. Intake of the high flavanol cocoa drink resulted in
significantly better performance on the global executive function
measures (p < 0.01), and an increase in serum brain-derived
neurotrophic factor (BDNF) levels (p < 0.01), relative to the
low flavanol cocoa drink intervention. BDNF is a member
of the neurotrophin family of growth factors that help to
stimulate and control neurogenesis. The authors additionally
conducted a randomized, controlled, dose-dependent, parallel
designed trial in 154 participants (aged 26–70 years) with
a high flavonoid fruit and vegetables (F&V) diet, or a low
flavonoid F&V diet, compared to a habitual control diet.
Participants consumed two portions of F&V for the first
6 weeks, followed by four portions for the next 6 weeks, and
finally six portions for the remaining 6 weeks, this equated
to 3, 6, and 7 mg/d in the low flavonoid intake group, and
49, 121, and 198 mg/d in the high flavonoid intake group.
All F&V were provided to the participants and effort was
taken to match the intake of other bioactive components of
F&V such as carotenoids, vitamin C, and folate. Cognitive
testing and blood sample collection occurred at weeks 0, 6,
12, and 18. Results showed significantly better performance on
the global executive function measures at 12 and 18 weeks
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for the high flavonoid F&V diet group relative to both
the low flavonoid F&V diet and the habitual control diet
(p < 0.01). Furthermore, serum BDNF was significantly higher
at 18 weeks in the high flavonoid F&V diet group relative to
the habitual control diet (p < 0.001). The authors concluded
that increased brain and peripheral BDNF expression could
be mediating the improvements observed in cognitive function
(Neshatdoust et al., 2016).
Flavanol-rich chocolate has been shown to counteract the
effects of sleep deprivation on working memory in women
but not men. Sixteen women and 16 men participated in a
randomized, double-blind, crossover study, undergoing four sets
of cognitive testing, two after a night of undisturbed sleep and
two after a night of total sleep deprivation, with a week between
each of the four testing sessions. Participants consumed either
a flavanol-poor chocolate bar or a flavanol-rich chocolate bar
before each of the testing sessions. Accuracy in the 2-back task
was significantly higher in the sleep deprivation condition when
the flavanol-rich chocolate was consumed, compared to the
flavanol-poor chocolate, in women only (p= 0.04). Consumption
of the flavanol-rich chocolate also produced positive effects
on blood pressure, flow-mediated dilation, and pulse-wave
velocity, which were all impaired following sleep deprivation
(Grassi et al., 2016).
The dentate gyrus (DG), a brain region in the hippocampal
formation, demonstrates functional decline with aging. In a
controlled randomized trial of 37 cognitively normal adults aged
50–69 years, Brickman et al. (2014) showed that consumption of
a high cocoa-containing diet for 3 months enhanced performance
on a novel object recognition task which localizes function
to the DG (high flavanol reaction time = 1,997 ms; low
flavanol reaction time = 2,627 ms; t31 = 2.17; p = 0.038;
Cohen’s d = 0.816). There was no effect of the diet on delayed
retention. The high flavanol group consumed two 450 mg
supplements per day, and the low flavanol group consumed
a total of 45 mg divided into two doses. The high flavanol
group also demonstrated a significant increase in cerebral blood
volume in the DG and the downstream subiculum in the body
of the hippocampus, with the changes in object recognition
task performance correlating with these cerebral blood volume
increases. The authors concluded that DG dysfunction is a driver
of age-related cognitive decline, and flavanol consumption may
be a method to ameliorate this process.
The effect of consumption of a high flavanol cocoa drink
compared to a low flavanol cocoa drink on cognitive function
was investigated in 90 cognitively normal elderly individuals
in a double-blind, controlled, parallel-arm study. Participants
were randomly assigned to groups consuming either a drink
containing 993 mg (high flavanol), 520 mg (intermediate
flavanol), or 48 mg (low flavanol) cocoa flavanols, daily for
8 weeks. No change in MMSE score in response to the three
treatments was observed. However, better performance on the
Trail Making Test A and B was observed after consumption
of the high and intermediate flavanol drinks, compared to the
low flavanol drink (p < 0.001). Verbal Fluency Test scores were
also significantly better after consumption of the high flavanol
drink, compared to the intermediate and low flavanol drinks
(p < 0.001). Additionally, significant improvements in insulin
resistance, blood pressure, and lipid peroxidation were seen in
the high and intermediate flavanol groups, in comparison to the
low flavanol group; highlighting potential mechanistic pathways
through which cocoa flavanols exert positive effects on cognition
(Mastroiacovo et al., 2015).
By contrast, Massee et al. (2015) found daily consumption
of cocoa supplementation (250 mg catechin polyphenols and
5.56 mg caffeine), for 4 weeks, had no effect on cognitive
performance in 40 young cognitively normal adults. However,
acute consumption, with cognitive testing conducted 3 h
after first supplementation, was associated with significant
improvement on Serial Sevens performance, in the first of
three cycles of cognitive testing. Notably, the intervention
duration was half that of Mastroiacovo et al. (2015), whilst
the quantity of flavanols consumed was considerably less than
the intermediate flavanol drink in that study. Additionally,
participants in the current study were considerably younger
with mean age 24.13 ± 4.47, and it is possible that by starting
cognitive testing 3 h post-flavanol consumption the peak in
flavanol concentration may have been missed.
A study investigating the effect of cocoa flavanol intake
combined with exercise on executive function found that,
whilst flavanol intake increased cerebral oxygenation during
the executive function task, there was no impact on cognitive
performance. Furthermore, exercise alone improved cognitive
function, however, there was no additive effect of the flavanol
consumption when combining the two conditions. The executive
function task comprised the Stroop test, and potentially this
short cognitive task was not sufficiently challenging for the
young, healthy cohort to show improvements. The cohort
comprised 12 males with a mean age of 30 ± 3 years, and
the study was randomized, double-blind, and crossover in
design (flavanol/placebo intake occurred 100 min preceding
a 30 min time trial), with flavanol consumption of 904 mg
(treatment), or 15 mg (control drink) (Decroix et al., 2016).
Furthermore, a study investigating cognitive function an hour
after consumption of either a low flavanol containing white
chocolate, a medium flavanol containing milk chocolate, or
a dark chocolate containing high flavanol levels, found no
improvements on a computerized test battery (Cogstate Ltd.).
The authors did, however, observe enhanced vascular endothelial
function following the high flavanol chocolate condition which
was reflected by improvements in brachial artery flow-mediated
dilation. The cohort was limited to 12 post-menopausal women,
but included strict control of the type, composition, and energy
content of the chocolate used to ensure consistency between
conditions (Marsh et al., 2017).
A cross-sectional study undertaken on 968 community-
dwelling participants between the ages of 23 and 98 years, drawn
from the Maine-Syracuse Longitudinal Study, showed that eating
chocolate more than once a week was associated with better
performance on a global cognitive composite (p < 0.001), as well
as better visual-spatial memory and organization (p < 0.001),
working memory (p= 0.048), scanning tracking (p < 0.001), and
abstract reasoning (p < 0.001), compared to eating chocolate less
than once a week. There were no associations observed between
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chocolate intake and verbal memory. An important point to note,
however, is that chocolate intake was not differentiated according
to type, i.e., dark, milk, or white, all of which contain varying
quantities of flavanols (Crichton et al., 2016).
Apple skin contains high concentrations of the flavanol
(−)-epicatechin and the flavonol quercetin. In a randomized,
controlled, crossover design study of 30 cognitively normal
participants, with mean age 47.3 ± 13.6, individuals received the
following treatments; (1) control: low flavonoid, low nitrate, (2)
apple: high flavonoid, low nitrate, (3) spinach: low flavonoid, high
nitrate, and (4) apple + spinach: high flavonoid, high nitrate
(the authors were also assessing effects from nitrates). There
was a minimum washout period of 1 week between treatments.
Relative to control, all treatments augmented nitric oxide status
acutely, but had no effect on cognitive function 150 min post-
intervention. The cognitive battery assessed “Quality Working
Memory,” “Power of Attention,” and “Continuity of Attention,”
and cognitive effects may have been evident with tasks measuring
additional domains. The “younger” age range of participants
and absence of cognitive impairment may also account for the
lack of observed effect. Furthermore, this study assessed the
acute effects of flavonoid intake, raising the possibility that
longer-term consumption is required to induce cognitive benefit
(Bondonno et al., 2014).
A 6-month bicentric, randomized, double-blind, placebo-
controlled trial conducted in 215 cognitively normal participants
(aged 60–70) receiving 600 mg/day of a flavanol-rich extract
from grape and blueberry, demonstrated improvements in
verbal episodic and recognition memory (VRM)-free recall in
the treatment group, with no effect observed on Cambridge
Neuropsychological Test Automated Battery (CANTAB) Paired
Associate Learning (PAL), a measure of visual-spatial learning
and episodic memory. However, there was a subgroup with
“advanced cognitive decline” who showed better VRM-delayed
recognition, post-flavanol treatment, only when the cohort was
stratified into quartiles using baseline PAL score. The authors
summarized that the study demonstrated a positive effect of
flavanol intake on episodic memory in otherwise cognitively
normal older adults with a lower level of memory performance
(Bensalem et al., 2019).
Moreover, a randomized, placebo-controlled, double-
blind, counterbalanced-crossover study of 20 healthy young
adults (mean age 21.05 ± SD 0.89) found 230 mL of
purple grape juice significantly improved reaction time,
compared to placebo, on a composite attention measure
(p = 0.047), 20 min after consumption. However, there was
no effect on attention accuracy, or on measures of memory
(Haskell-Ramsay et al., 2017).
Of the 15 studies reviewed in this section, 11 found
improvements in at least one cognitive domain following flavanol
consumption (two observational studies, six chronic, and three
acute intervention studies). Of these 11 studies, flavanol intake
was associated with improvements in global cognition as well as
the cognitive domains of visual-spatial memory and organization,
working memory, abstract reasoning, accuracy, reaction time,
executive function, episodic memory, verbal fluency, and
recognition memory. There were no common methodological
approaches amongst the studies reporting positive effects
compared to those reporting no effect, with a wide range of age
groups included, varying flavanol doses utilized and two studies
incorporating the additional variables of sleep deprivation and
exercise. Factors likely impacting the varying results reported are
discussed in greater detail in the “Discussion.”
FLAVANONES
Orange juice is one of the most commonly consumed juices
throughout the world and is a rich source of flavanones,
particularly hesperidin and narirutin. As one of the most readily
absorbed flavonoid subclasses, flavanones have been shown to
cross the blood-brain barrier. In summary, we have reviewed
two acute studies (<24 h) and one chronic study (duration
8 weeks) investigating flavanones from orange juice in cognitively
normal participants (both young and older participants), and one
prospective cohort study examining long-term intake of total and
the six classes of dietary flavonoids over a follow-up period of up
to 15 years, in dementia-free individuals aged 45 years and over.
High flavanone (HF; 305 mg) 100% orange juice and a low
flavanone (LF; 37 mg) orange-flavored cordial were consumed
daily for 8 weeks by 37 cognitively normal older adults (mean age
67 years) in a crossover, double-blind, randomized study, with
a 4 weeks wash out period between treatments. After 8 weeks
of consuming the HF drink, global cognitive performance
was significantly better than after the LF drink intervention
(t = 2.86; p < 0.05). In other cognitive areas, the HF drink
reduced the decline in performance associated with LF beverage
consumption. Further, performance was better when the HF
drink was consumed in the first arm of the trial than when the
LF drink was consumed first, indicating effects of the HF drink
may have continued into the second arm of the intervention
(Kean et al., 2015).
The effect of drinking a HF orange juice (272 mg) compared
with placebo has been investigated acutely, with cognitive testing
conducted at 2- and 6-h post-consumption, in a randomized,
double-blind, counterbalance study, with a 2-week wash out
period. This study was conducted in 22 healthy males between
30 and 65 years of age. The HF drink contained 220.46 mg
hesperidin, 34.54 mg narirutin, and other flavonoids (17.14 mg).
Performance on the Simple Finger Tapping test, a measure of
psychomotor speed (involves pressing the “2” key as many times
with the index finger over a 10 s period) was better, following
the HF drink, relative to placebo [F(1,20) = 8.32; p < 0.01].
Additionally, the change in performance from baseline to 6 h
post-consumption on Continuous Performance Task accuracy, a
measure of psychomotor speed, was significantly different across
the treatments, with fewer errors observed when the HF drink
had been consumed. This test involves random presentation of
letters at a rate of one every 250 ms for a duration of 6 min, and
participants are required to press the space bar when a letter other
than “X” is presented (Alharbi et al., 2016).
Lamport et al. (2016) investigated acute effects of HF juice
consumption (orange and grapefruit juice) compared to a
concentrated cordial drink containing zero flavonoids. The HF
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drink contained considerably less total flavanones than the
previously mentioned studies, with 70.5 mg present (42.15 mg
hesperidin, 17.25 mg naringin, 6.75 mg narirutin, and 4.3 mg
caffeic acid); however, the drink also contained additional
flavanones in greater proportions, for example naringin. Twenty-
four young adults between 18 and 30 years of age underwent
cognitive testing at baseline and 2 h post-drink consumption, and
a further 16 participants underwent functional MRI assessment
at baseline, 2- and 5-h post-drink consumption to measure
cerebral blood flow (CBF). The authors observed significantly
improved performance on the Digit Symbol Substitution Test
(DSST) 2 h after consumption of the HF drink, with no
improvements following consumption of the control drink
[F(1,23)= 10.76, p < 0.01]; however, other cognitive tests showed
no improvements. Regional perfusion in the inferior frontal gyrus
and middle frontal gyrus of the right hemisphere was significantly
higher 2 h post-consumption of the HF drink compared with the
control drink. There were no differences in regional perfusion
5 h after consumption of either drink. The inferior frontal gyrus
has been implicated in tasks that require inhibition, planning,
decision making, and other aspects of executive function,
examined by the DSST. Stronger cognitive effects could have
occurred more than 2 h post-drink consumption, as was seen
in the previously mentioned studies, yet this was not assessed
in the current study. However, increased CBF was observed
at 2 h and not 5 h post-consumption in the current study,
suggesting that the time course by which flavonoids in orange
and grapefruit juice exert their effect may differ from orange
juice alone. It is not possible, however, to determine a direct
link between increased CBF and better cognitive function in the
current study due to the separate cohorts utilized to investigate
these outcomes.
All three studies reviewed thus far in this section reported
improvements in at least one cognitive domain following
flavanone consumption (one chronic study and two acute).
Global cognition as well as the cognitive domains of psychomotor
speed, and executive function were positively impacted by
flavanone consumption. All three studies also reported no
associations of flavanone intake with episodic memory and verbal
memory. These three studies were conducted in cohorts of
distinct age groups of cognitively normal adults, ranging from 30
to over 65 years. It appears therefore, that flavanone intake yields
positive effects on cognition regardless of age. Further discussion
of these results in conjunction with the results of the anthocyanin
and flavanol studies is included in the “Discussion.”
Finally, a recent study assessed the association of long-
term intake of total and six classes of dietary flavonoids
(flavanones, flavan-3-ols, flavonoid polymers, flavonols, flavones,
and anthocyanins) and decline in cognitive function, over a
median follow-up period of up to 11.8 years, in 1779 participants
who were dementia free, aged ≥45 years at commencement,
and who attended at least two study assessments (approximately
4 years apart). The findings did not support a clear association,
with nominally significant trends observed between (1) higher
flavonol and flavan-3-ol intakes, and slower decline in global
function, verbal and visual memory; (2) higher total flavonoid
and flavonoid polymer intakes and slower decline in visual
memory; and (3) slower decline in verbal learning with higher
flavanol intake (Shishtar et al., 2020). The age range of
participants, and sensitivity of cognitive measures used, may have
impacted the study findings.
MECHANISMS OF ACTION
Having a clear understanding of how these flavonoid subclasses
are modulating cognitive function is required for furthering
the use of these compounds as interventions which can be
recommended by health professionals. For example, knowledge
of a compound’s mechanism of action enables better dosing
through monitoring of the compound’s effects on the target
pathway in the patient. There is a relative paucity of data in
humans, with the majority of mechanistic studies to date, having
been undertaken in animal models. Nevertheless, these animal
studies provide clues regarding potential mechanistic pathways in
humans. Collectively, the published studies implicate a number
of candidate mechanisms underlying the beneficial effects of
consumption of these flavonoid subclasses on cognitive function,
including, modulation of intracellular signaling pathways,
altered CBF, and conferring protection against neurotoxins and
neuroinflammation.
Modulation of Signaling Cascades
The flavonoid subclasses of anthocyanins, flavanols, and
flavanones modulate several neurological processes via their
interaction with signaling pathways involved in neuronal
survival and function, upregulation of proteins important
for synaptic plasticity and neuronal repair, and inhibition
of neuropathological processes which occur in brain regions
typically implicated in AD pathogenesis.
Various flavonoids interact with important cell survival
signaling pathways including the phosphatidylinositol-3
kinase/Akt (PI3K/Akt), extracellular signal-regulated protein
kinase (ERK), and protein kinase C pathways [PKC; (Levites et al.,
2002; Spencer, 2007; Vauzour et al., 2007; Williams et al., 2008)].
Flavonoids have also been shown to modulate the cell death
pathways mediated by p38 and c-Jun N-terminal kinase (Hwang
and Yen, 2009) to confer protection against neurodegeneration.
These interactions are summarized in Figure 1.
The activation of cell survival pathways by flavonoids involves
upregulation of anti-apoptotic and pro-survival genes, and
inhibition of pro-apoptotic proteins (Levites et al., 2002; Spencer,
2007). Targets include inhibition of apoptosis signal-regulating
kinase 1 (ASK1; Vauzour et al., 2007), and non-transcriptional
inhibition of BclxL/Bcl2-associated death promoter (Bad), BCL2-
associated X protein (Bax), and murine double minute 2 (Mdm2;
Levites et al., 2002). Flavonoids are also proposed to confer
cell survival through activation of cAMP response element-
binding protein (CREBP) phosphorylation (Williams et al.,
2008) and increases in levels of BDNF (Williams et al., 2008).
As mentioned previously, BDNF is a neurotrophin required
for the development and maintenance of the nervous system
(Schindowski et al., 2008). BDNF levels are known to decline
during aging, and their levels have been shown to correlate
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FIGURE 1 | Modulation of neuronal death and survival pathways by the flavonoid subclasses of anthocyanins, flavanols, and flavanones. Modified from Solanki et al.
(2015). AP-1, activated protein 1; ASK1, apoptosis signal-regulating kinase 1; Bad, BclxL/Bcl-2-associated death promoter; Bax, Bcl-2-associated X protein; Bcl-2,
B-cell CLL/lymphoma 2; Bcl-w, BCL2-like 1; BDNF, Brain-derived Neurotropic Factor; CREB, cAMP response element-binding protein; ERK, extracellular
signal-regulated protein kinase; JNK, c-Jun N-terminal kinase; Mdm2, murine double minute 2; PI3K/Akt, phosphatidylinositol-3 kinase/Protein kinase B; PKC,
protein kinase C.
with learning and memory (Garzon et al., 2002; Hwang et al.,
2006; Laske et al., 2006). JNK and p38 are strongly linked
to transcription-dependent apoptotic signaling (Mielke and
Herdegen, 2000) via the activation of c-Jun and other activated
protein 1 (AP-1) proteins including Jun-B and Jun-D (Behrens
et al., 1999): flavonoids have been shown to impact these
pathways at multiple levels to confer antiapoptotic activity
(Ramiro-Puig et al., 2009).
The inflammatory cascade is believed to play a critical role
in the development of chronic low grade inflammatory diseases
such as AD. Reductions in blood levels of inflammatory markers
such as CRP, IL-6, and tumor necrosis factor alpha (TNF-α) have
been shown following flavonoid consumption, suggesting anti-
inflammatory activity (Carey et al., 2014; Macready et al., 2014).
Furthermore, flavonoids have the capacity to downregulate the
activity of pro-inflammatory transcription factors such as NF-κB,
nuclear factor erythroid 2-related factor 2 (Nrf2) and STAT
(signal transducers and activators of transcription), through their
influences on a number of glial and neuronal signaling pathways
(Hamalainen et al., 2007; Risitano et al., 2014).
Mitochondria control cellular energy status, reactive oxygen
species (ROS) production, and apoptosis, all of which are
important for determining lifespan, and mitochondria are
therefore, proposed to act as central organelles in the regulation
of aging and neurodegeneration. Mitochondria constitute the
major source of superoxide and other ROS within most
tissues. AMP-activated protein kinase (AMPK), a key cellular
regulator of energy metabolism, has been implicated in the
regulation of mitochondria function. Damaged mitochondria
are the major sources of ROS in cells and are implicated
in many neurodegenerative diseases including AD. Activated
AMPK can decrease intracellular ROS by inhibiting NADPH
(nicotinamide adenine dinucleotide phosphate) oxidase activity,
or by increasing the expression of antioxidant enzymes
such as superoxide dismutase-2 and uncoupling protein-2
(Manczak et al., 2006). Flavonoids may ameliorate mitochondrial
dysfunction and increase oxidative defense mechanisms by
activating AMPK (Cordero-Herrera et al., 2013).
Indirect Benefits to Cerebrovasculature
Consumption of flavonoids could improve cerebrovascular
outcomes including CBF. Whilst the mechanisms require
elucidation, they may be related to increases in the pool of
bioavailable nitric oxide (NO; Bondonno et al., 2012), which
is a key signaling molecule responsible for mediating vascular
function changes (Heiss et al., 2007). Flavonoids may enhance
NO levels by preventing NO breakdown, which could occur
by a direct reaction with superoxide and other ROS and/or
inhibition of the enzymes that produce these molecules [xanthine
oxidase, lipoxygenase, and NADPH oxidase; (Nijveldt et al.,
2001; Mladenka et al., 2010)]. One mechanism by which NO
is synthesized is by the action of endothelial nitric oxide
synthase (eNOS) on arginine, and flavonoids may enhance NO
production by increasing eNOS activity or enhancing expression.
Decreases in blood pressure, improvements in endothelial
function (Bondonno et al., 2012), and improvements in CBF have
all been observed in association with an increase in NO status
(Francis et al., 2006). This is consistent with literature showing
natural products that enhance brain metabolism or elevate CBF
are effective at augmenting cognitive function during prolonged,
effortful, cognitive processing (Owen and Sunram-Lea, 2011),
with reduced blood flow to the brain associated with cognitive
impairment (Farkas et al., 2002).
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Moreover, there is evidence to show that increasing
glucoregulatory control via improved insulin sensitivity can
improve cognitive function, with intake of flavonoids being
shown to increase insulin sensitivity, as well as insulin and
glucose levels (Russo et al., 2019). Attenuation of decline in blood
glucose concentrations has been observed following blackcurrant
(Watson et al., 2015) and cranberry (Wilson et al., 2008;
Torronen et al., 2010) consumption, which suggests glucose
regulation may be an additional mechanism through which
flavonoids confer cognitive benefit, particularly in the immediate
postprandial period where the majority of improvements in
cognitive performances were observed.
DISCUSSION
Evidence accumulated to date suggests the consumption of
products containing anthocyanins, flavanols, and flavanones,
such as berries and cocoa, throughout life, may have the potential
to limit or even reverse age-related declines in cognition and
memory, and potentially delay the onset and progression of
neurodegenerative diseases such as AD. Over the last 6 years, the
flavonoid subgroups of anthocyanins, flavanols, and flavanones
have been shown to be beneficial in terms of conferring
neuroprotection and cognitive benefit. Of note, however,
methodological disparities hinder comparison of results between
studies. For example, a vast range of flavonoid-containing
products utilized in interventions of varying durations, and
differences in comprehensiveness of neuropsychological
assessments, as well as heterogeneity of cohorts, are all likely to
impact findings.
Of the literature reviewed here, acute studies ranged in
duration from 60 min to 6 h, whilst the longer-term studies
ranged from 28 days to 6 months, with 3 months being the
most common timeframe employed. All except two intervention
studies included control groups consuming a placebo, with these
two studies comparing cognitive function at baseline to end point
(16 weeks or 6 h). Whilst studies were included in the current
review regardless of placebo being matched with the intervention
condition for macro- and micro- nutrient content, this should
be a consideration when designing future interventions, to
ensure observed effects are due to the flavonoid content and
not additional components (e.g., caffeine which has independent
effects on alertness, mood, arousal, and concentration). The
quantity of flavonoid treatment in the reviewed studies also
varied greatly, with some participants consuming 900 mg daily
or greater, and others under 100 mg. Interestingly, a study
including groups of participants consuming 993 mg or 520 mg
daily, for 8 weeks, found both quantities were associated with
improvements in measures of attention, visual search and
scanning, sequencing and shifting, and psychomotor speed, but
only the 993 mg group also demonstrated increased performance
in verbal fluency (Mastroiacovo et al., 2015).
A range of cognitive domains have been shown to be
beneficially affected in the reviewed studies; summarized in
Figure 2. Acute supplementation with the three flavonoid
FIGURE 2 | Cognitive domains affected by the flavonoid subclasses of anthocyanins, flavanols, and flavanones.
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subclasses investigated was associated with positive effects in tests
measuring psychomotor speed, executive function, and attention.
Longer-term supplementation was associated with positive effects
in tests of episodic memory, global cognition, verbal fluency,
psychomotor speed, and verbal memory, in multiple studies.
Although a particular task may have a primary focus such as
verbal fluency or episodic memory, a range of processes may
support the primary focus, e.g., memory, processing speed, and
motor function. Potentially, flavonoids could be exerting greater
effects on relatively effortful tasks and less effect on simpler tasks.
This notion is consistent with the results of Bondonno et al.
(2014), who utilized a computerized cognitive assessment battery
which was not heavily loaded with cognitive processing tasks,
and yielded no significant associations. Furthermore, Gratton
et al. (2020) showed improvements in cognitive function only
when cognitive demand is high; significant associations were only
observed 2 h following high flavanol consumption in the Double
Stroop condition and not in the standard word and color Stroop
conditions. A wide range of tasks which fully assess cognitive
ability (multiple domains and tasks of varying complexity) needs
to be employed by studies attempting to fully characterize the
effects of flavonoids on cognition.
The mechanisms by which the flavonoid subclasses of
anthocyanins, flavanols, and flavanones modulate cognitive
function are yet to be fully established. Available evidence
plausibly suggests these flavonoid subclasses can promote
beneficial effects via both direct (i.e., through receptor activation,
neurotrophin, and signaling pathway modulation) and indirect
actions (i.e., enhancement of CBF). Although, it should be
noted that the majority of mechanistic studies to date have
been conducted in animal models, and more human studies are
required to draw definitive conclusions.
Wide inter-individual variability in flavonoid absorption and
metabolism has been reported, with a number of factors including
age and gender affecting these metabolic processes. Flavonoids
initially undergo extensive metabolization by phase I and II
metabolism which occur predominantly in the gastrointestinal
tract and liver. Hepatic perfusion and morphology reduce as part
of the aging process, which has been suggested to reduce phase
I and II metabolism of flavonoids. Flavonoid absorption occurs
in both the small and large intestines, with a high percentage
reaching the colon where there is exposure to colonic microbiota
(Williamson and Clifford, 2010). The microbiome plays a
key role in catabolizing unabsorbed flavonoids into smaller
molecules which may become bioavailable. It is conceivable
that heterogeneity in flavonoid absorption and metabolism may
diminish beneficial associations between intakes and cognitive
outcomes reported in studies. Ideally, urinary flavonoid excretion
results would be taken into account in analyses, and to inform
personalized health goals.
FUTURE RESEARCH
Overall, additional prospective studies conducted in diverse
populations, and adequately powered intervention studies with
long durations, are required to thoroughly examine the effect
of consumption of the flavonoid subclasses of anthocyanins,
flavanols, and flavanones on clinically relevant cognitive
outcomes. Moreover, the characterization of appropriate dosage,
timeframes for intake, and form of flavonoids, remains to be
fully determined. Whilst animal models have shown promising
results with interventions of timeframes such as 2 months, this
represents a considerably larger percentage of total lifespan for
animals than it does for humans, and a longer time-frame
could be needed to show enhanced outcomes in human trials.
Both acute and chronic effects of these flavonoid subclasses
also need to be investigated using neuroimaging techniques in
conjunction with cognitive and physiological measures to further
elucidate the underlying biological mechanisms. Furthermore,
it should be acknowledged that studies in cognitively normal
adults are unlikely to demonstrate large improvements in
cognitive function, and therefore it is imperative that suitable,
sensitive cognitive tests are utilized. There is currently no
clear evidence regarding the specific domains of cognition and
memory that these flavonoid subclasses impact, with future
studies requiring a range of cognitive domains to be investigated
in order to determine those most likely to benefit. If emerging
evidence continues to suggest significant cognitive benefit,
another important consideration is the optimum age for the
initiation of supplementation of flavonoid intake. Indeed, the
neuropathological hallmarks of AD begin to accumulate 15–
20 years before symptoms manifest, implying that the optimal
age for supplementing flavonoid consumption could be middle-
age or younger.
CONCLUSION
As populations continue to focus on developing strategies to
promote healthy aging, dietary interventions with flavonoids
represents a promising avenue for future research. However,
many questions still need to be answered before a definite
conclusion can be made regarding the extent to which
consumption of anthocyanins, flavanols, and flavanones can
protect the aging brain, and intake can be included in public
health dietary recommendations.
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